why choose us

Clinical Trials Search

Showing 3,530 of 132,085 result(s)
Mental Health Burden and Help-seeking Behavior in the Austrian General Population

Status: COMPLETED

Condition: Screening

Interventions:

Date: 2024-09-27

A Study to Learn How Safe BAY3018250 is, How it Moves Into, Through and Out of the Body, and How it Affects the Body in Healthy Chinese Participants

Status: COMPLETED

Condition: Acute Venous and Arterial Thrombotic and Thromboembolic Events

Interventions: Single dose

Date: 2024-09-27

Orofacial Pain in Woodwind and Cello Musicians in German Orchestras

Status: COMPLETED

Condition: Orofacial Pain

Interventions: The online questionnaire includes demographic data: age, gender, instrument (oboe, flute, clarinet, bassoon, and cello), years of service, number of s

Date: 2024-09-27

Effect of a Nutritional Supplement With Phytoglycogen on Gut-brain Axis With Focus to Perceived Stress, Mood and Sleep

Status: COMPLETED

Condition: Perceived Stress

Interventions: microcrystalline cellulose; 200 mg ;day; 1 capsule;day; 1 capsule daily with breakfast

Date: 2024-09-27

A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

Status: COMPLETED

Condition: Acute Pain

Interventions: Tablets for oral administration.

Date: 2024-09-27

Financial Navigation and Peer Support to Improve Diabetes Outcomes

Status: COMPLETED

Condition: Diabetes Mellitus

Interventions: A combined intervention of technology-supported financial navigation and peer support: A professional financial navigator from TailorMed will use the

Date: 2024-09-27

FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression

Status: COMPLETED

Condition: Bipolar Depression

Interventions: Open-label Ketamine

Date: 2024-09-26

Efficacy Study of the Probiotic Food Supplement PROBAFLOR for Maintaining Intestinal Well-being

Status: COMPLETED

Condition: Gut

Interventions: PROBAFLOR is a food supplement made up of 11 bacterial strains and inulin.
The bacterial strains present are: Bifidobacterium lactis BLC1, Lactoc

Date: 2024-09-26

AZAHAR Study To Describe Anifrolumab in a Real-World Setting

Status: COMPLETED

Condition: Systemic Lupus Erythematosus (SLE)

Interventions:

Date: 2024-09-26

AZAHAR Study To Describe Anifrolumab in a Real-World Setting

Status: COMPLETED

Condition: Systemic Lupus Erythematosus (SLE)

Interventions:

Date: 2024-09-26